Redux Bio

Private

San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.reduxbio.com/

Last Round

Seed

Nov 12, 2021

Total Funding Raised

$3M

Company Overview

Redux Bio is an aquaculture company that develops preventative disease management tools as sustainable alternatives to antibiotics for livestock and aquaculture farmers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

animal healthRNAi biotechnologyaquaculture healthRNAi therapeuticsantibiotic alternativesagritechaquatechshrimp farmingRNA interferenceantiviral medicineWhite Spot Syndrome VirusWSSVlivestock healthorally-delivered medicinepreventative animal healthengineered microalgae

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Redux Bio Comparables

Compare Redux Bio with similar companies based on industry and business-model similarity.

Redux Bio comparables — related companies by embedding similarity
Company	Similarity	Market Cap
ViAqua Therapeutics	87%
AquaNab Solutions	76%
Boehringer Ingelheim	61%

View all Comparables

Redux Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Nov 12, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Lincoln Tubbs

Chief Executive Officer

Executive Team

Redux Bio Investors

Notable investors and investment history

Redux Bio investors
Investor	Rounds
Genoa Ventures	Seed

View all Investors

Redux Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Redux Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Redux Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California

Employee Range6

Year Founded2021

Last FundingNov 12, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?